CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 62.514
AS - Asia 37.676
EU - Europa 29.652
SA - Sud America 4.683
AF - Africa 510
OC - Oceania 161
Continente sconosciuto - Info sul continente non disponibili 64
AN - Antartide 1
Totale 135.261
Nazione #
US - Stati Uniti d'America 61.030
SG - Singapore 12.522
CN - Cina 8.539
VN - Vietnam 7.042
HK - Hong Kong 5.621
IT - Italia 5.488
RU - Federazione Russa 5.079
DE - Germania 4.449
BR - Brasile 3.888
SE - Svezia 3.531
IE - Irlanda 3.179
UA - Ucraina 2.543
GB - Regno Unito 1.532
CA - Canada 1.098
FI - Finlandia 787
IN - India 710
KR - Corea 674
FR - Francia 652
AT - Austria 599
ID - Indonesia 504
JP - Giappone 373
NL - Olanda 365
TR - Turchia 354
AR - Argentina 333
BD - Bangladesh 277
DK - Danimarca 275
MX - Messico 258
ZA - Sudafrica 238
LT - Lituania 235
PL - Polonia 220
ES - Italia 191
IQ - Iraq 162
BE - Belgio 153
EC - Ecuador 143
AU - Australia 131
PK - Pakistan 108
IR - Iran 97
TW - Taiwan 81
SA - Arabia Saudita 70
CO - Colombia 67
UZ - Uzbekistan 65
EG - Egitto 64
MY - Malesia 64
PY - Paraguay 63
VE - Venezuela 61
EU - Europa 53
CH - Svizzera 52
IL - Israele 50
CZ - Repubblica Ceca 48
AE - Emirati Arabi Uniti 46
MA - Marocco 46
PE - Perù 44
KZ - Kazakistan 43
JO - Giordania 41
PT - Portogallo 41
TN - Tunisia 38
UY - Uruguay 36
RO - Romania 35
CL - Cile 33
GR - Grecia 33
KE - Kenya 31
PH - Filippine 28
AZ - Azerbaigian 27
NZ - Nuova Zelanda 25
HR - Croazia 22
NP - Nepal 22
TH - Thailandia 22
BG - Bulgaria 21
DO - Repubblica Dominicana 21
AL - Albania 20
CR - Costa Rica 20
ET - Etiopia 20
KG - Kirghizistan 18
OM - Oman 18
HN - Honduras 17
NO - Norvegia 17
RS - Serbia 17
DZ - Algeria 16
JM - Giamaica 16
BH - Bahrain 15
LB - Libano 15
PA - Panama 14
BO - Bolivia 12
HU - Ungheria 11
LV - Lettonia 11
PS - Palestinian Territory 11
MD - Moldavia 10
SC - Seychelles 10
AO - Angola 9
GT - Guatemala 9
KW - Kuwait 9
TT - Trinidad e Tobago 9
SY - Repubblica araba siriana 8
LU - Lussemburgo 7
NI - Nicaragua 7
BN - Brunei Darussalam 6
BY - Bielorussia 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
Totale 135.149
Città #
Ann Arbor 9.449
Singapore 7.171
Hong Kong 5.546
Woodbridge 4.641
Ashburn 4.455
Dallas 4.331
Fairfield 3.561
Houston 3.494
Dublin 3.082
Chandler 2.845
Jacksonville 2.537
Frankfurt am Main 2.433
Wilmington 2.288
Ho Chi Minh City 2.180
Milan 1.778
Dearborn 1.763
Hanoi 1.615
New York 1.537
Seattle 1.419
Santa Clara 1.325
Beijing 1.267
Princeton 1.244
Cambridge 1.186
Hefei 966
Los Angeles 839
Nanjing 727
Boardman 599
Shanghai 548
The Dalles 505
Vienna 485
Hangzhou 462
Seoul 460
Lawrence 459
Moscow 458
Altamura 450
Chicago 417
Lachine 413
Buffalo 400
Jakarta 392
São Paulo 367
Council Bluffs 365
Guangzhou 323
Dong Ket 256
Munich 248
Toronto 243
Nanchang 220
Helsinki 213
San Diego 207
Shenyang 207
Andover 206
Rome 206
Vilnius 195
Tokyo 194
Haiphong 193
Da Nang 175
London 164
Ha Long 161
Nuremberg 160
Changsha 159
Hebei 154
Biên Hòa 153
Tianjin 149
Rio de Janeiro 147
Warsaw 138
Falls Church 136
Hải Dương 134
Jinan 128
Brooklyn 127
Phoenix 122
Ottawa 121
Quận Bình Thạnh 121
Jiaxing 119
Fremont 117
Brussels 116
Grafing 112
Kazan 112
Atlanta 111
Johannesburg 110
Montreal 106
Stockholm 106
Denver 103
Chennai 101
Thái Nguyên 101
Mountain View 100
Ninh Bình 98
Columbus 97
Pune 96
Salt Lake City 93
San Jose 92
Zhengzhou 92
Boston 91
Kent 91
Detroit 90
Can Tho 89
Norwalk 89
Mexico City 86
Orem 86
Huizen 85
Vũng Tàu 85
Bắc Ninh 82
Totale 88.675
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.033
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 697
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 608
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 567
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 548
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 519
CIPN and its mechanism of development 517
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 507
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 503
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 465
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 465
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 464
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 455
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 446
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 442
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 421
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 421
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 396
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 395
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 393
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 391
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 391
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 388
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 388
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 385
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 381
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 377
Malattie del Sistema Nervoso 375
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 372
Age-related changes in the function and structure of the peripheral sensory pathway in mice 370
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 366
A role for hemopexin in oligodendrocyte differentiation and myelin formation 364
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 364
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 363
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 362
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 360
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 360
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 357
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 357
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 352
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 351
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 341
Enhanced brain targeting of engineered solid lipid nanoparticles 341
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials 341
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 334
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 333
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 331
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 327
The Italian multiple sclerosis register 323
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 320
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 319
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 308
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 305
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 305
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 303
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 303
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 302
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 301
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 301
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 297
Malattie del Sistema Nervoso 296
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 295
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 295
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 291
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 291
Role of MAPKs in platinum-induced neuronal apoptosis 288
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 288
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 287
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 286
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 285
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 283
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 279
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 276
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 276
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 275
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 274
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 273
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 272
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 272
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 269
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 268
In vitro anticancer activity and neurotoxicity of novel heavy metal-based anticancer complexes 266
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 265
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 265
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 264
Are sigma receptor modulators a weapon against multiple sclerosis disease? 264
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 261
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 261
Sex dimorphism in an animal model of multiple sclerosis: Focus on pregnenolone synthesis 261
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 260
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 260
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 259
Totale 35.459
Categoria #
all - tutte 457.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 457.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.054 0 0 0 0 0 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202525.492 1.585 2.872 1.748 1.200 2.163 931 1.391 976 2.945 3.306 2.243 4.132
2025/202637.333 9.639 5.703 7.297 5.637 6.147 2.910 0 0 0 0 0 0
Totale 139.332